MICROPORT(00853): Shanghai MicroPort Endovascular MedTech(Group)Co.,Ltd. achieved a net profit attributable to shareholders of 155 million yuan in the first quarter of technology, a year-on-year increase of 19.44%.

18:40 29/04/2026

Weigao Medical (00853) released the performance report for the first quarter of 2026 of Shanghai Weigao Heart and Vascular Medical Technology (Group) Co., Ltd. The company achieved revenue of 370 million yuan (in the same unit), an increase of 11.45% year-on-year; the net profit attributable to the shareholders of Heart and Vascular Medical Technology was 155 million yuan, an increase of 19.44% year-on-year.

MICROPORT (00853) releases the first quarter performance of Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd. in 2026. The company achieved revenue of 370 million yuan (all units in the text), a year-on-year increase of 11.45%; the net profit attributable to the shareholders of Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd. was 155 million yuan, a year-on-year increase of 19.44%.

RENZE HARVEST (01282) intends to sell Hong Kong property for approximately HKD 38.206 million.

Net profit attributable to the parent company in the first quarter of CMSC (06099) was 3.271 billion yuan, an increase of 41.73% year-on-year.

Metallurgical Corporation of China (01618) had a net profit of 1.633 billion yuan in the first quarter, an increase of 1.59% year-on-year.

RENZE HARVEST (01282) intends to sell Hong Kong property for approximately HKD 38.206 million.

Net profit attributable to the parent company in the first quarter of CMSC (06099) was 3.271 billion yuan, an increase of 41.73% year-on-year.

Metallurgical Corporation of China (01618) had a net profit of 1.633 billion yuan in the first quarter, an increase of 1.59% year-on-year.